These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33177793)

  • 21. [Clinical and molecular characterization of gastrointestinal stromal tumors (GIST)].
    Mac K; Wójcik M
    Postepy Hig Med Dosw (Online); 2007 Jun; 62():272-81. PubMed ID: 18542042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
    Croom KF; Perry CM
    Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New fronts in the adjuvant treatment of GIST.
    Reichardt P; Joensuu H; Blay JY
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):715-23. PubMed ID: 23934322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal stromal tumor.
    Gupta P; Tewari M; Shukla HS
    Surg Oncol; 2008 Aug; 17(2):129-38. PubMed ID: 18234489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrointestinal stromal tumor--background, pathology, treatment.
    Eisenberg BL; Pipas JM
    Hematol Oncol Clin North Am; 2012 Dec; 26(6):1239-59. PubMed ID: 23116579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term survival of a case with multiple liver metastases from duodenal gastrointestinal stromal tumor drastically reduced by the treatment with imatinib and hepatectomy.
    Sakakura C; Hagiwara A; Soga K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yamaoka N; Sagara Y; Yamagishi H
    World J Gastroenterol; 2006 May; 12(17):2793-7. PubMed ID: 16718773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical analysis of 156 patients with gastrointestinal stromal tumors receiving imatinib therapy].
    Zhang L; Cai M; Deng J; Wang X; Wang B; Liu N; Pan Y; Zhang R; Cui Q; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):331-4. PubMed ID: 24760639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The importance of mutational status in prognosis and therapy of GIST].
    Comandone A; Boglione A
    Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imatinib and beyond in gastrointestinal stromal tumors: A radiologist's perspective.
    Tirumani SH; Jagannathan JP; Krajewski KM; Shinagare AB; Jacene H; Ramaiya NH
    AJR Am J Roentgenol; 2013 Oct; 201(4):801-10. PubMed ID: 24059369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of recurrent gastrointestinal stromal tumors.
    Winer JH; Raut CP
    J Surg Oncol; 2011 Dec; 104(8):915-20. PubMed ID: 21337345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571).
    Demetri GD
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S52-9. PubMed ID: 12528773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary extra-gastrointestinal stromal tumor of the omentum.
    Divakaran J; Chander B
    J Cancer Res Ther; 2012; 8(3):433-5. PubMed ID: 23174729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment and Prognoses in Patients With Primary Gastrointestinal Stromal Tumors ≥10  cm: A Single-Institution Experience in China.
    Shen C; Chen H; Yin Y; Chen J; Tang S; Zhang B; Han L; Chen Z; Chen J
    Medicine (Baltimore); 2015 Jul; 94(28):e1117. PubMed ID: 26181546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal stromal tumors.
    Taneva I; Dimitrova V
    Khirurgiia (Sofiia); 2011; (1):39-47. PubMed ID: 23847801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up outcome of imatinib mesylate treatment for recurrent and unresectable gastrointestinal stromal tumors.
    Saito S; Nakata K; Kajiura S; Ando T; Hosokawa A; Sugiyama T
    Digestion; 2013; 87(1):47-52. PubMed ID: 23343969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    ESMO / European Sarcoma Network Working Group
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii49-55. PubMed ID: 22997454
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment strategy for recurrent and metastatic gastrointestinal stromal tumors].
    Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):309-11. PubMed ID: 24760634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-320a downregulation is associated with imatinib resistance in gastrointestinal stromal tumors.
    Gao X; Shen K; Wang C; Ling J; Wang H; Fang Y; Shi Y; Hou Y; Qin J; Sun Y; Qin X
    Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):72-5. PubMed ID: 24217767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gastrointestinal stromal tumour (GIST): current standards in multimodal management].
    Reichardt P; Reichardt A
    Zentralbl Chir; 2011 Aug; 136(4):359-63. PubMed ID: 21863513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rare case of gastrointestinal stromal tumor presenting with closed perforation of the small intestine.
    Andican A; Gökçal F; Agayeva A; Gülşen F; Özden F; Özben V
    Turk J Gastroenterol; 2012 Jun; 23(3):253-7. PubMed ID: 22798115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.